EGFR and glioblastoma: Among the protein markers expressed preferentially on GBM cells that could be targeted by therapeutic modalities, several studies have focused on EGFR (epidermal growth factor receptor), either the wild type or its variants, mainly EGFRvIII (EGFR variant 3, in-frame deletion of exons 2 to 7).